Your browser doesn't support javascript.
loading
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation.
Dragon, Anna Christina; Zimmermann, Katharina; Nerreter, Thomas; Sandfort, Deborah; Lahrberg, Julia; Klöß, Stephan; Kloth, Christina; Mangare, Caroline; Bonifacius, Agnes; Tischer-Zimmermann, Sabine; Blasczyk, Rainer; Maecker-Kolhoff, Britta; Uchanska-Ziegler, Barbara; Abken, Hinrich; Schambach, Axel; Hudecek, Michael; Eiz-Vesper, Britta.
Afiliación
  • Dragon AC; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Zimmermann K; Institute for Experimental Hematology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Nerreter T; Department of Internal Medicine II, Universitätsklinikum Würzburg, Wuerzburg, Bayern, Germany.
  • Sandfort D; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Lahrberg J; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Klöß S; Institute of Cellular Therapeutics, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Kloth C; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Sachsen, Germany.
  • Mangare C; Institute for Experimental Hematology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Bonifacius A; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Tischer-Zimmermann S; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Blasczyk R; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Maecker-Kolhoff B; Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Uchanska-Ziegler B; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Abken H; Ziegler Biosolutions, Waldshut-Tiengen, Baden-Wuertemberg, Germany.
  • Schambach A; Regensburg Center for Interventional Immunology (RCI), Department of Genetic Immunotherapy, Universitätsklinikum Regensburg, Regensburg, Bayern, Germany.
  • Hudecek M; Institute for Experimental Hematology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Eiz-Vesper B; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 8(2)2020 10.
Article en En | MEDLINE | ID: mdl-33127653
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígenos HLA-B / Inmunoterapia Adoptiva / Antígenos Nucleares del Virus de Epstein-Barr / Epítopos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antígenos HLA-B / Inmunoterapia Adoptiva / Antígenos Nucleares del Virus de Epstein-Barr / Epítopos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Alemania